retatrutide constipation Retatrutide Side Effects: What We Know So Far What is the first‑line therapy

Commenting on future research, Gasoyan told MNT that future studies should examine the comparative effectiveness of treatments for obesity in patients who discontinue their novel GLP-1 RA or dual receptor agonist medication. We are already working on the next study, where we examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions

Dehydration can lead to poor circulation and a decrease in blood volume, both of which make it harder for your body to maintain a steady temperature

The problem is that this would be significantly expensive for the states

Whether you can access GLP-1s through this model depends entirely on whether your state chooses to participate